-+ 0.00%
-+ 0.00%
-+ 0.00%

Boston Scientific Approves 2026 Global Restructuring Program; Plans Intends To Cut Headcount;. Expects ~$700M - $800M As Pre-Tax Charges; Plan Expected To Reduce Annual Pre-Tax Expenses by $500M

Benzinga·07/27/2026 20:10:37
Listen to the news

https://www.sec.gov/ix?doc=/Archives/edgar/data/885725/000088572526000049/bsx-20260721.htm